From: Clinical outcomes after IL-6 blockade in patients with COVID-19 and HIV: a case series
Pt | Sex | Age | Race/ethnicity | Location | Most recent VL | CD4 | ART | Comorbid conditions |
---|---|---|---|---|---|---|---|---|
1 | F | 60 | White, non-Hispanic | Int | Undetectable | 600 | 2 NRTIs + PI + INSTI | COPD, CKD, Cirrhosis |
2 | M | 39 | Hispanic, white | Int | Undetectable | 354 | 2 NRTIs + INSTI | HTN |
3 | M | 74 | Black, non-Hispanic | MA | Undetectable | 238 | 2 NRTIs + INSTI | HTN, CKD, malignancy |
4 | F | 76 | Black, non-Hispanic | PA | Undetectable | 205 | 2 NRTIs + INSTI | HTN, DM, Asthma, CKD |
5 | M | 61 | White, non-Hispanic | NY | 29 | 62 | 2 NRTIs + INSTI + CYP3Ai + PI | Asthma |
6 | M | 60 | Hispanic; non-white | NY | Undetectable | 1200 | 2 NRTIs + INSTI | None |
7 | M | 59 | Hispanic; non-white | NY | Undetectable | 298 | NNRTI + INSTI | HTN, DM |
8 | F | 68 | Hispanic, non-white | NY | Undetectable | 186 | 2 NRTIs + INSTI | Cirrhosis |
9 | M | 80 | Black. non-Hispanic | NY | Undetectable | 296 | 2 NRTIs + NNRTI | HTN, CKD |
10 | F | 39 | White, non-Hispanic | NY | Unknown | 85 | 2 NRTIs + INSTI | None |
11 | M | 29 | Hispanic, non-white | NY | Undetectable | 465 | 2 NRTIs + INSTI | HTN |
12 | M | 36 | Hispanic, white | TX | 24 | 328 | 2 NRTIs + NNRTI | None |
13 | M | 70 | White, non-Hispanic | TX | Undetectable | 260 | 2 NRTIs + INSTI | COPD, CKD |
14 | F | 57 | Black, non-Hispanic | PA | 84 | 250 | 2 NRTIs + INSTI | HTN, DM, CKD |
15 | M | 81 | Hispanic, non-white | TX | 91 | 345 | 2 NRTIs + PI | DM, malignancy |
16 | M | 70 | White, non-Hispanic | TX | Undetectable | 260 | 2 NRTIs + NNRTI | COPD |
17 | M | 61 | Hispanic, non-white | NY | Undetectable | NR | 2 NRTIs + INSTI | HTN, CAD |
18 | M | 57 | Black, non-Hispanic | MD | 326 | 111 | N/A | None |